Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study

被引:1
|
作者
Yu, Shaobin [1 ]
You, Chengxiong [1 ]
Yan, Renhe [2 ]
Chen, Hui [3 ]
Chen, Chao [1 ]
Xu, Shaojun [1 ]
Gonzalez, Michel [4 ]
Chen, Ruiqin [1 ]
Kang, Mingqiang [1 ,5 ,6 ,7 ]
Chen, Shuchen [1 ,5 ,6 ,7 ,8 ]
机构
[1] Fujian Med Univ, Dept Thorac Surg, Union Hosp, Fuzhou, Peoples R China
[2] Fujian Med Univ, Dept Cardiothorac Surg, Nanping Hosp 1, Nanping, Peoples R China
[3] Ningde Normal Univ, Dept Thorac & Cardiac Surg, Ningde Municipal Hosp, Ningde, Peoples R China
[4] Lausanne Univ Hosp CHUV, Serv Thorac Surg, Lausanne, Switzerland
[5] Fujian Med Univ, Fujian Prov Univ, Key Lab Cardiothorac Surg, Fuzhou, Peoples R China
[6] Fujian Med Univ, Sch Basic Med Sci, Key Lab Gastrointestinal Canc, Minist Educ, Fuzhou, Peoples R China
[7] Fujian Med Univ, Dept Med Microbiol, Fujian Key Lab Tumor Microbiol, Fuzhou, Peoples R China
[8] Fujian Med Univ, Dept Thorac Surg, Union Hosp, 29 Xinquan Rd, Fuzhou 350001, Peoples R China
关键词
Nomogram; lung adenocarcinoma; IA3; stage; recurrence-free survival (RFS); GROUND-GLASS OPACITY; PROGNOSTIC IMPACT; TUMOR VOLUME; 8TH EDITION; CANCER; MICROPAPILLARY; CLASSIFICATION; COMPONENT;
D O I
10.21037/tlcr-22-776
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The increased use of computed tomography has brought a corresponding increase in the numbers of early-stage lung cancer patients receiving treatment. However, even for stage IA3 lung adenocarcinoma, many patients experience postoperative recurrence and metastasis. The existing TNM staging system for lung cancer does not take many clinical and pathological factors into consideration, resulting in the failure to detect and intervene as soon as possible in those with high recurrence risk. The purpose of this study was to explore the risk factors for postoperative recurrence-free survival (RFS) in patients with stage IA3 lung adenocarcinoma, and to construct and verify a nomogram model for predicting RFS in patients with the disease.Methods: This study analyzed patients with stage IA3 lung adenocarcinoma who underwent surgical treatment. Univariate and multivariate analysis were used to analyze the independent risk factors for postoperative RFS and establish a nomogram model. Concordance index (C-index), receiver operating characteristic curve, clinical decision analysis, and calibration curve were used to evaluate the discrimination and calibration of the nomogram model. Data from two other institutions were used for external validation, and the nomogram scores were combined with X-tile software to screen high-risk groups of recurrence.Results: The internal cohort included 235 eligible patients with stage IA3 lung adenocarcinoma from 7,235 lung cancer. Multivariate analysis showed smoking, solid nodules, mucinous lung adenocarcinoma, and micropapillary component >= 5% were independent risk factors for RFS. A nomogram model was constructed based on the above results and the bootstrap method was used for internal validation. The internal and external validation C-indexes of the nomogram were 0.822 (95% CI: 0.751-0.891) and 0.812, respectively, indicating the obvious prediction performance was good. The X-tile software combined with nomogram scores showed the low-risk group (5-RFS rate, 0.65-0.99) had better RFS than the high-risk group (5-RFS rate, 0.20-0.65) (P<0.0001). Conclusions: We constructed a nomogram model for predicting postoperative RFS in patients with stage IA3 lung adenocarcinoma which can individually evaluate the risk of postoperative recurrence, screen high-risk groups, and develop individualized follow-up and intervention strategies to improve the survival rate of the patients.
引用
收藏
页码:2275 / 2288
页数:14
相关论文
共 50 条
  • [1] Development and validation of a nomogram based on preoperative variables for predicting recurrence-free survival in stage IA lung adenocarcinoma
    Xu, Jiaxi
    Zeng, Hui
    Zhang, Guochao
    Li, Renda
    Yuan, Zhenlong
    Ren, Jingyu
    Huang, Yufei
    Ren, Fangzhou
    Zhang, Hao
    Fei, Kailun
    Feng, Feiyue
    Tan, Fengwei
    THORACIC CANCER, 2023, 14 (31) : 3108 - 3118
  • [2] A unique gene signature predicting recurrence-free survival in stage IA lung adenocarcinoma
    Carr, Shamus R.
    Wang, Haitao
    Hudlikar, Rasika
    Lu, Xiaofan
    Zhang, Mary R.
    Hoang, Chuong D.
    Yan, Fangrong
    Schrump, David S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 165 (04):
  • [3] Establishment and validation of a clinicopathological prediction model for postoperative recurrence of stage IA lung adenocarcinoma
    Zhang, Xin
    Yang, Jie
    Li, Shining
    Ao, Yong
    Zhong, Leqi
    Liu, Xinyu
    Luo, Kongjia
    Hu, Yi
    JOURNAL OF THORACIC DISEASE, 2024, 16 (05) : 3061 - 3074
  • [4] Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma
    Yang, Yao-Cheng
    Wang, Jun-Jie
    Huang, Yun
    Cai, Wei-Xin
    Tao, Qian
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4403 - 4416
  • [5] Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
    Li, Yinuo
    Hou, Xin
    Chen, Wei
    Wang, Shixuan
    Ma, Xiangyi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
    Yinuo Li
    Xin Hou
    Wei Chen
    Shixuan Wang
    Xiangyi Ma
    Scientific Reports, 13
  • [7] Establishment and Validation of Coagulation Factor-Based Nomogram for Predicting the Recurrence-Free Survival of Prostate Cancer
    Jin, Chen
    Bian, Zichen
    Mo, Fan
    Zhu, Chenyu
    Tao, Zhi
    Jin, Xiaoyan
    Zhou, Jun
    Zhang, Meng
    Meng, Jialin
    Liang, Chaozhao
    UROLOGIA INTERNATIONALIS, 2022, 106 (09) : 954 - 962
  • [8] Development and Validation of a Nomogram for Predicting Postoperative Recurrence-Free Survival in Patients With Nonmetastatic Pathological T3a Stage Renal Cell Carcinoma
    Li, Xintao
    Huang, Qingbo
    Gu, Liangyou
    Wu, Shengpan
    Li, Jianye
    Zhang, Xu
    Yang, Minghui
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [9] Construction of methylation-associated nomogram for predicting the recurrence-free survival risk of stage I-III lung adenocarcinoma
    Liu, Youcai
    Wang, Bin
    Shi, Shiqiang
    Li, Zhaoxi
    Wang, Yajuan
    Yang, Jie
    FUTURE ONCOLOGY, 2021,
  • [10] Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study
    Xu, Shao-Jun
    Chen, Rui-Qin
    Tu, Jia-Hua
    You, Cheng-Xiong
    Chen, Chao
    Zhang, Zhi-Fan
    Divisi, Duilio
    Migliore, Marcello
    Bongiolatti, Stefano
    Durand, Marion
    Sato, Masaaki
    Kuroda, Hiroaki
    Yang, Chao-Fu
    Yu, Shao-Bin
    Chen, Shu-Chen
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (05) : 1078 - +